These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9534101

  • 1. Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
    Hansen JF.
    J Hypertens Suppl; 1998 Jan; 16(1):S71-4. PubMed ID: 9534101
    [Abstract] [Full Text] [Related]

  • 2. Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.
    Hansen JF, Hagerup L, Sigurd B, Pedersen F, Mellemgaard K, Bjergaard OP.
    Am Heart J; 1997 Aug; 134(2 Pt 2):S48-52. PubMed ID: 9313623
    [Abstract] [Full Text] [Related]

  • 3. Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group).
    Hansen JF, Hagerup L, Sigurd B, Pedersen F, Mellemgaard K, Pedersen-Bjergaard O.
    J Hypertens Suppl; 1997 Mar; 15(2):S119-22. PubMed ID: 9218208
    [Abstract] [Full Text] [Related]

  • 4. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
    Hansen JF, Hagerup L, Sigurd B, Pedersen F, Mellemgaard K, Pedersen-Bjergaard O, Mortensen LS.
    Am J Cardiol; 1997 Mar 15; 79(6):738-41. PubMed ID: 9070551
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 15; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 6. Preventing microalbuminuria in type 2 diabetes.
    Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B, Gaspari F, Perna A, Bossi A, Trevisan R, Dodesini AR, Remuzzi G, Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators.
    N Engl J Med; 2004 Nov 04; 351(19):1941-51. PubMed ID: 15516697
    [Abstract] [Full Text] [Related]

  • 7. [Gopten (trandolapril) in the treatment of chronic heart failure in patients with ischemic heart disease].
    Kakhnovskiĭ IM, Fomina IG, Ostroumov EL, Lepeshkov VM, Gaĭdamakina NE, Kaveshnikova OV, Markova ZS, Lugovaia EL.
    Ter Arkh; 1998 Nov 04; 70(8):29-33. PubMed ID: 9770740
    [Abstract] [Full Text] [Related]

  • 8. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S, Messerli FH, Cohen JD, Bacher PH, Sleight P, Mancia G, Kowey P, Zhou Q, Champion A, Pepine CJ, INVEST Investigators.
    Am Heart J; 2008 Aug 04; 156(2):241-7. PubMed ID: 18657652
    [Abstract] [Full Text] [Related]

  • 9. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction].
    Aliot E.
    Arch Mal Coeur Vaiss; 1996 Aug 04; 89 Spec No 3():23-31. PubMed ID: 8949315
    [Abstract] [Full Text] [Related]

  • 10. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb 04; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 11. Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.
    Boero R, Rollino C, Massara C, Vagelli G, Gonella M, Berto IM, Bajardi P, Perosa P, Malcangi U, Giorgi MP, Ghezzi PM, Borzumati M, Baroni AM, Cogno C, Triolo G, Angelini D, Antonelli A, Quarello F.
    J Nephrol; 2001 Feb 04; 14(1):15-8. PubMed ID: 11281338
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study].
    Rosolová H, Cech F, Sefrna F.
    Vnitr Lek; 2002 Aug 04; 48(8):701-6. PubMed ID: 12425199
    [Abstract] [Full Text] [Related]

  • 13. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M.
    J Hypertens Suppl; 1997 Mar 04; 15(2):S27-33. PubMed ID: 9218195
    [Abstract] [Full Text] [Related]

  • 14. The fixed combination of verapamil SR/trandolapril.
    Widimský J.
    Expert Opin Pharmacother; 2000 Mar 04; 1(3):515-35. PubMed ID: 11249535
    [Abstract] [Full Text] [Related]

  • 15. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J, Dzúrik R.
    Vnitr Lek; 1998 Jun 04; 44(6):326-31. PubMed ID: 9820054
    [Abstract] [Full Text] [Related]

  • 16. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov 04; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats.
    Richer C, Mulder P, Fornes P, Domergue V, Heudes D, Giudicelli JF.
    J Cardiovasc Pharmacol; 1992 Jul 04; 20(1):147-56. PubMed ID: 1383624
    [Abstract] [Full Text] [Related]

  • 18. Trandolapril: a newer angiotensin-converting enzyme inhibitor.
    Guay DR.
    Clin Ther; 2003 Mar 04; 25(3):713-75. PubMed ID: 12852701
    [Abstract] [Full Text] [Related]

  • 19. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB, Curran MP, Perry CM.
    Drugs; 2002 Mar 04; 62(17):2539-67. PubMed ID: 12421112
    [Abstract] [Full Text] [Related]

  • 20. Is a combination of verapamil and an ACE-inhibitor the optimal solution in ischaemic heart failure?
    Jespersen CM.
    Cardiologia; 1995 Dec 04; 40(12 Suppl 1):307-10. PubMed ID: 8903054
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.